Showing results (81-90 of 101) with videos related to
Sort By:
Pageof 11
Molecular Immunology|November 26, 2008
Chirality of TLR-2 ligand Pam3CysSK4 in fully synthetic peptide conjugates critically influences the induction of specific CD8+ T-cellsSelina Khan, Jimmy J Weterings, Cedrik M Britten, et al.Cancer Immunology, Immunotherapy : CII|September 19, 2012
The development of standard samples with a defined number of antigen-specific T cells to harmonize T cell assays: a proof-of-principle studySatwinder Kaur Singh, Bart Tummers, Ton N Schumacher, et al.Cancer Research|January 13, 2012
Exploiting the mutanome for tumor vaccinationJohn C Castle, Sebastian Kreiter, Jan Diekmann, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2003
Maturation of dendritic cells is a prerequisite for inducing immune responses in advanced melanoma patientsI Jolanda M de Vries, W Joost Lesterhuis, Nicole M Scharenborg, et al.Cancer Immunology Research|June 22, 2014
Efficient induction of antitumor immunity by synthetic toll-like receptor ligand-peptide conjugatesGijs G Zom, Selina Khan, Cedrik M Britten, et al.Cancer Immunology, Immunotherapy : CII|November 17, 2010
Minimal information about T cell assays: the process of reaching the community of T cell immunologists in cancer and beyondC M Britten, S Janetzki, S H van der Burg, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 21, 2006
Phase II trial of a toll-like receptor 9-activating oligonucleotide in patients with metastatic melanomaMikhail Pashenkov, Gerda Goëss, Christine Wagner, et al.Cancer Immunology, Immunotherapy : CII|August 20, 2014
Harmonisation of short-term in vitro culture for the expansion of antigen-specific CD8(+) T cells with detection by ELISPOT and HLA-multimer stainingLindsey Chudley, Katy J McCann, Adam Coleman, et al.Cancer Immunology, Immunotherapy : CII|July 1, 2015
Monitoring regulatory T cells in clinical samples: consensus on an essential marker set and gating strategy for regulatory T cell analysis by flow cytometrySaskia J A M Santegoets, Eveline M Dijkgraaf, Alessandra Battaglia, et al.Cancer Immunology, Immunotherapy : CII|January 1, 2005
A phase I vaccination study with tyrosinase in patients with stage II melanoma using recombinant modified vaccinia virus Ankara (MVA-hTyr)Ralf G Meyer, Cedrik M Britten, Ulrike Siepmann, et al.Pageof 11